FGF21 for use in treating type 1 diabetes

• 收藏
• 分享

专利权人:

Amgen Inc.

发明人:

Ellison, Murielle Marie,Stanislaus, Shanaka,Xu, Jing

申请号：

AU2012301769

公开号：

AU2012301769B2

申请日:

2012.08.30

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

Methods of treating metabolic diseases and disorders using a FGF21 polypeptide are provided. In various embodiments the metabolic disease or disorder is type 1 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels, diabetic nephropathy, neuropathy, retinopathy, ischemic heart disease, peripheral vascular disease and cerebrovascular disease

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/